![Lee Arnold](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Lee Arnold
Företagsledare/Principal på
Institute of Chemical Biology & Drug Discovery
Profil
Lee D.
Arnold is the founder of Discoverelucidations LLC, founded in 2007, serving as President & Chief Executive Officer from 2007 to 2018.
Dr. Arnold was the founder of Pardes Biosciences, Inc., founded in 2020, serving as Chief Scientific Officer from 2020 to 2022.
Dr. Arnold currently holds the position of Member at the Institute of Chemical Biology & Drug Discovery.
Former jobs include Vice President-Research at OSI Pharmaceuticals, Inc. in 2007; Principal at Pfizer Inc.; Principal at Syntex Corp.; Chief Scientific Officer & Vice President at BlinkBio, Inc. from 2009 to 2014; Chief Scientific Officer at Aethlon Medical, Inc. from 2023 to 2024; Principal at AbbVie Bioresearch Center, Inc.; Chief Discovery Officer at Assembly Biosciences, Inc. in 2016; and Senior Vice President-Research at Kinnate Biopharma, Inc. from 2018 to 2020.
Education includes a doctorate from the University of Alberta and an undergraduate degree from The University of Waterloo.
Aktiva positioner av Lee Arnold
| Företag | Position | Start |
|---|---|---|
Institute of Chemical Biology & Drug Discovery | Företagsledare/Principal | - |
Tidigare kända positioner av Lee Arnold
| Företag | Position | Slut |
|---|---|---|
| AETHLON MEDICAL, INC. | Teknisk/Vetenskaplig/F&U Direktör | 2024-07-01 |
| PARDES BIOSCIENCES, INC. | Grundare | 2022-10-01 |
| KINNATE BIOPHARMA INC. | Företagsledare/Principal | 2020-04-01 |
Discoverelucidations LLC | Verkställande Direktör | 2018-04-01 |
| ASSEMBLY BIOSCIENCES, INC. | Teknisk/Vetenskaplig/F&U Direktör | 2016-01-01 |
Lee Arnolds utbildningar
Erfarenheter
Innehade positioner
Aktiva
Inaktiva
Börsnoterade företag
Privata företag
Relationer
59
Första gradens relationer
13
Företag kopplade till första graden
Man
Kvinna
Styrelseledamöter
Chefer
Kopplade företag
| Privata företag | 13 |
|---|---|
OSI Pharmaceuticals, Inc.
 OSI Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and develops pharmaceutical drugs | Health Technology |
Pfizer Inc.
 Pfizer Inc. Pharmaceuticals: MajorHealth Technology Engages in discovery, development, manufacturing, marketing, sale and distribution of biopharmaceutical products & ingredients | Health Technology |
Syntex Corp.
 Syntex Corp. Pharmaceuticals: MajorHealth Technology Pharmaceutical concern | Health Technology |
Aethlon Medical, Inc.
 Aethlon Medical, Inc. Medical SpecialtiesHealth Technology Provides diagnostic and therapeutic device solutions for infectious disease, cancer & for other life threatening conditions | Health Technology |
BlinkBio, Inc.
 BlinkBio, Inc. Pharmaceuticals: MajorHealth Technology Develops orally active drugs that act like small drug molecules | Health Technology |
University of Alberta
 University of Alberta Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
The University of Waterloo
 The University of Waterloo Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
AbbVie Bioresearch Center, Inc.
 AbbVie Bioresearch Center, Inc. BiotechnologyHealth Technology Provides drug discovery, development sciences and biologics research services | Health Technology |
Discoverelucidations LLC | |
Assembly Biosciences, Inc.
 Assembly Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Engages in the development of products for infectious diseases | Health Technology |
Institute of Chemical Biology & Drug Discovery | |
Kinnate Biopharma, Inc.
 Kinnate Biopharma, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage precision oncology company | Health Technology |
Pardes Biosciences, Inc.
 Pardes Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that develops oral antiviral treatment for COVID-19 | Health Technology |
